nodes	percent_of_prediction	percent_of_DWPC	metapath
Trihexyphenidyl—CHRM5—Tiotropium—chronic obstructive pulmonary disease	0.316	0.369	CbGbCtD
Trihexyphenidyl—CHRM3—Tiotropium—chronic obstructive pulmonary disease	0.202	0.236	CbGbCtD
Trihexyphenidyl—CHRM1—Tiotropium—chronic obstructive pulmonary disease	0.176	0.205	CbGbCtD
Trihexyphenidyl—CHRM2—Tiotropium—chronic obstructive pulmonary disease	0.162	0.189	CbGbCtD
Trihexyphenidyl—Angle closure glaucoma—Tiotropium—chronic obstructive pulmonary disease	0.0105	0.0785	CcSEcCtD
Trihexyphenidyl—Ileus paralytic—Tiotropium—chronic obstructive pulmonary disease	0.00652	0.0489	CcSEcCtD
Trihexyphenidyl—Intraocular pressure increased—Tiotropium—chronic obstructive pulmonary disease	0.00641	0.0481	CcSEcCtD
Trihexyphenidyl—Cognitive impairment—Prednisone—chronic obstructive pulmonary disease	0.00343	0.0257	CcSEcCtD
Trihexyphenidyl—Memory impairment—Montelukast—chronic obstructive pulmonary disease	0.00284	0.0213	CcSEcCtD
Trihexyphenidyl—Intraocular pressure increased—Prednisolone—chronic obstructive pulmonary disease	0.0028	0.021	CcSEcCtD
Trihexyphenidyl—Mydriasis—Salbutamol—chronic obstructive pulmonary disease	0.00269	0.0202	CcSEcCtD
Trihexyphenidyl—Weight decreased—Roflumilast—chronic obstructive pulmonary disease	0.00254	0.0191	CcSEcCtD
Trihexyphenidyl—Cognitive disorder—Prednisone—chronic obstructive pulmonary disease	0.00207	0.0155	CcSEcCtD
Trihexyphenidyl—Intraocular pressure increased—Prednisone—chronic obstructive pulmonary disease	0.00204	0.0153	CcSEcCtD
Trihexyphenidyl—Hyperkinesia—Montelukast—chronic obstructive pulmonary disease	0.00194	0.0146	CcSEcCtD
Trihexyphenidyl—Tension—Roflumilast—chronic obstructive pulmonary disease	0.00192	0.0144	CcSEcCtD
Trihexyphenidyl—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.0019	0.0143	CcSEcCtD
Trihexyphenidyl—Dry skin—Tiotropium—chronic obstructive pulmonary disease	0.00188	0.0141	CcSEcCtD
Trihexyphenidyl—Hyperkinesia—Salbutamol—chronic obstructive pulmonary disease	0.00187	0.014	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Salbutamol—chronic obstructive pulmonary disease	0.00185	0.0138	CcSEcCtD
Trihexyphenidyl—Mydriasis—Prednisolone—chronic obstructive pulmonary disease	0.00154	0.0116	CcSEcCtD
Trihexyphenidyl—Dry skin—Arformoterol—chronic obstructive pulmonary disease	0.00151	0.0114	CcSEcCtD
Trihexyphenidyl—Dry skin—Formoterol—chronic obstructive pulmonary disease	0.00151	0.0114	CcSEcCtD
Trihexyphenidyl—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00137	0.0103	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00132	0.00988	CcSEcCtD
Trihexyphenidyl—Tension—Aminophylline—chronic obstructive pulmonary disease	0.00128	0.00962	CcSEcCtD
Trihexyphenidyl—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.00127	0.00952	CcSEcCtD
Trihexyphenidyl—Delusion—Prednisone—chronic obstructive pulmonary disease	0.00126	0.00949	CcSEcCtD
Trihexyphenidyl—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00125	0.00935	CcSEcCtD
Trihexyphenidyl—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.0012	0.00901	CcSEcCtD
Trihexyphenidyl—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.0012	0.009	CcSEcCtD
Trihexyphenidyl—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00116	0.00871	CcSEcCtD
Trihexyphenidyl—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00115	0.0086	CcSEcCtD
Trihexyphenidyl—Memory impairment—Prednisone—chronic obstructive pulmonary disease	0.00114	0.00855	CcSEcCtD
Trihexyphenidyl—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.00111	0.00835	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Prednisolone—chronic obstructive pulmonary disease	0.00106	0.00794	CcSEcCtD
Trihexyphenidyl—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00106	0.00793	CcSEcCtD
Trihexyphenidyl—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00104	0.0078	CcSEcCtD
Trihexyphenidyl—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00102	0.00762	CcSEcCtD
Trihexyphenidyl—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00101	0.00756	CcSEcCtD
Trihexyphenidyl—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00101	0.00755	CcSEcCtD
Trihexyphenidyl—Headache—Roflumilast—chronic obstructive pulmonary disease	0.001	0.00751	CcSEcCtD
Trihexyphenidyl—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000981	0.00736	CcSEcCtD
Trihexyphenidyl—Tension—Formoterol—chronic obstructive pulmonary disease	0.000976	0.00732	CcSEcCtD
Trihexyphenidyl—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000976	0.00732	CcSEcCtD
Trihexyphenidyl—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000966	0.00724	CcSEcCtD
Trihexyphenidyl—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000966	0.00724	CcSEcCtD
Trihexyphenidyl—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00095	0.00712	CcSEcCtD
Trihexyphenidyl—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000921	0.00691	CcSEcCtD
Trihexyphenidyl—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000914	0.00685	CcSEcCtD
Trihexyphenidyl—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000914	0.00685	CcSEcCtD
Trihexyphenidyl—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000912	0.00684	CcSEcCtD
Trihexyphenidyl—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000895	0.00671	CcSEcCtD
Trihexyphenidyl—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000863	0.00647	CcSEcCtD
Trihexyphenidyl—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00086	0.00645	CcSEcCtD
Trihexyphenidyl—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.00082	0.00615	CcSEcCtD
Trihexyphenidyl—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000792	0.00594	CcSEcCtD
Trihexyphenidyl—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000792	0.00594	CcSEcCtD
Trihexyphenidyl—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000781	0.00586	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000769	0.00577	CcSEcCtD
Trihexyphenidyl—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000748	0.00561	CcSEcCtD
Trihexyphenidyl—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000721	0.00541	CcSEcCtD
Trihexyphenidyl—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000721	0.00541	CcSEcCtD
Trihexyphenidyl—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000707	0.0053	CcSEcCtD
Trihexyphenidyl—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000705	0.00529	CcSEcCtD
Trihexyphenidyl—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000694	0.0052	CcSEcCtD
Trihexyphenidyl—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000694	0.0052	CcSEcCtD
Trihexyphenidyl—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000681	0.00511	CcSEcCtD
Trihexyphenidyl—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000678	0.00508	CcSEcCtD
Trihexyphenidyl—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000672	0.00504	CcSEcCtD
Trihexyphenidyl—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000672	0.00504	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000669	0.00502	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000669	0.00502	CcSEcCtD
Trihexyphenidyl—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000668	0.00501	CcSEcCtD
Trihexyphenidyl—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000665	0.00499	CcSEcCtD
Trihexyphenidyl—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000655	0.00491	CcSEcCtD
Trihexyphenidyl—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000639	0.0048	CcSEcCtD
Trihexyphenidyl—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000635	0.00476	CcSEcCtD
Trihexyphenidyl—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000634	0.00476	CcSEcCtD
Trihexyphenidyl—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000633	0.00475	CcSEcCtD
Trihexyphenidyl—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000633	0.00475	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000631	0.00474	CcSEcCtD
Trihexyphenidyl—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00063	0.00472	CcSEcCtD
Trihexyphenidyl—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000597	0.00448	CcSEcCtD
Trihexyphenidyl—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000596	0.00447	CcSEcCtD
Trihexyphenidyl—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000582	0.00437	CcSEcCtD
Trihexyphenidyl—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000582	0.00437	CcSEcCtD
Trihexyphenidyl—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00057	0.00428	CcSEcCtD
Trihexyphenidyl—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00055	0.00412	CcSEcCtD
Trihexyphenidyl—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000537	0.00402	CcSEcCtD
Trihexyphenidyl—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000537	0.00402	CcSEcCtD
Trihexyphenidyl—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000526	0.00394	CcSEcCtD
Trihexyphenidyl—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000516	0.00387	CcSEcCtD
Trihexyphenidyl—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000516	0.00387	CcSEcCtD
Trihexyphenidyl—Rash—Formoterol—chronic obstructive pulmonary disease	0.000512	0.00384	CcSEcCtD
Trihexyphenidyl—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000512	0.00384	CcSEcCtD
Trihexyphenidyl—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000511	0.00383	CcSEcCtD
Trihexyphenidyl—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000511	0.00383	CcSEcCtD
Trihexyphenidyl—Headache—Formoterol—chronic obstructive pulmonary disease	0.000508	0.00381	CcSEcCtD
Trihexyphenidyl—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000508	0.00381	CcSEcCtD
Trihexyphenidyl—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000508	0.00381	CcSEcCtD
Trihexyphenidyl—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000507	0.00381	CcSEcCtD
Trihexyphenidyl—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000507	0.0038	CcSEcCtD
Trihexyphenidyl—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000505	0.00379	CcSEcCtD
Trihexyphenidyl—Rash—Montelukast—chronic obstructive pulmonary disease	0.000501	0.00376	CcSEcCtD
Trihexyphenidyl—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000501	0.00376	CcSEcCtD
Trihexyphenidyl—Headache—Montelukast—chronic obstructive pulmonary disease	0.000498	0.00373	CcSEcCtD
Trihexyphenidyl—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000487	0.00365	CcSEcCtD
Trihexyphenidyl—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000483	0.00362	CcSEcCtD
Trihexyphenidyl—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000483	0.00362	CcSEcCtD
Trihexyphenidyl—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000482	0.00362	CcSEcCtD
Trihexyphenidyl—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000482	0.00362	CcSEcCtD
Trihexyphenidyl—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00048	0.0036	CcSEcCtD
Trihexyphenidyl—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000472	0.00354	CcSEcCtD
Trihexyphenidyl—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000455	0.00341	CcSEcCtD
Trihexyphenidyl—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000447	0.00335	CcSEcCtD
Trihexyphenidyl—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000429	0.00322	CcSEcCtD
Trihexyphenidyl—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000369	0.00277	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000362	0.00272	CcSEcCtD
Trihexyphenidyl—Agitation—Prednisone—chronic obstructive pulmonary disease	0.00036	0.0027	CcSEcCtD
Trihexyphenidyl—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000312	0.00234	CcSEcCtD
Trihexyphenidyl—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000291	0.00218	CcSEcCtD
Trihexyphenidyl—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000277	0.00208	CcSEcCtD
Trihexyphenidyl—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000277	0.00208	CcSEcCtD
Trihexyphenidyl—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000275	0.00206	CcSEcCtD
Trihexyphenidyl—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000273	0.00205	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000263	0.00197	CcSEcCtD
Trihexyphenidyl—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000261	0.00196	CcSEcCtD
Trihexyphenidyl—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000229	0.00172	CcSEcCtD
Trihexyphenidyl—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000211	0.00158	CcSEcCtD
Trihexyphenidyl—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000203	0.00152	CcSEcCtD
Trihexyphenidyl—Rash—Prednisone—chronic obstructive pulmonary disease	0.000201	0.00151	CcSEcCtD
Trihexyphenidyl—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000201	0.00151	CcSEcCtD
Trihexyphenidyl—Headache—Prednisone—chronic obstructive pulmonary disease	0.0002	0.0015	CcSEcCtD
Trihexyphenidyl—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00019	0.00142	CcSEcCtD
Trihexyphenidyl—CHRM2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	3.54e-05	0.00343	CbGpPWpGaD
Trihexyphenidyl—CHRM1—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	3.49e-05	0.00338	CbGpPWpGaD
Trihexyphenidyl—CHRM3—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	3.48e-05	0.00337	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	3.45e-05	0.00334	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	3.44e-05	0.00333	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	3.43e-05	0.00332	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	3.4e-05	0.0033	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	3.39e-05	0.00328	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	3.34e-05	0.00323	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	3.28e-05	0.00318	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	3.24e-05	0.00314	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—APIP—chronic obstructive pulmonary disease	3.2e-05	0.0031	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	3.2e-05	0.0031	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	3.12e-05	0.00302	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	3.11e-05	0.00301	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	3.06e-05	0.00297	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.01e-05	0.00291	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2.98e-05	0.00289	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	2.95e-05	0.00286	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	2.95e-05	0.00285	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	2.94e-05	0.00285	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	2.93e-05	0.00284	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	2.92e-05	0.00283	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	2.9e-05	0.00281	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	2.88e-05	0.00279	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2.86e-05	0.00277	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	2.85e-05	0.00276	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	2.8e-05	0.00271	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.73e-05	0.00265	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	2.7e-05	0.00261	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	2.69e-05	0.0026	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	2.68e-05	0.0026	CbGpPWpGaD
Trihexyphenidyl—CHRM4—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	2.66e-05	0.00258	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	2.66e-05	0.00258	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	2.64e-05	0.00256	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.64e-05	0.00256	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	2.63e-05	0.00255	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.61e-05	0.00253	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.61e-05	0.00253	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	2.61e-05	0.00253	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.53e-05	0.00245	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	2.51e-05	0.00244	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	2.51e-05	0.00243	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.5e-05	0.00242	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	2.48e-05	0.00241	CbGpPWpGaD
Trihexyphenidyl—CHRM2—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	2.46e-05	0.00238	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	2.4e-05	0.00233	CbGpPWpGaD
Trihexyphenidyl—CHRM2—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	2.36e-05	0.00229	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	2.31e-05	0.00224	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	2.3e-05	0.00223	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	2.28e-05	0.00221	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	2.28e-05	0.00221	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	2.28e-05	0.00221	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	2.25e-05	0.00218	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	2.25e-05	0.00218	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	2.24e-05	0.00217	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	2.22e-05	0.00215	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.12e-05	0.00206	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.12e-05	0.00205	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—GC—chronic obstructive pulmonary disease	2.06e-05	0.002	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	2.03e-05	0.00196	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.03e-05	0.00196	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	2.02e-05	0.00196	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2.01e-05	0.00195	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2e-05	0.00194	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	2e-05	0.00194	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2e-05	0.00194	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	2e-05	0.00194	CbGpPWpGaD
Trihexyphenidyl—CHRM2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	2e-05	0.00194	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.98e-05	0.00192	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.92e-05	0.00186	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.92e-05	0.00186	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	1.89e-05	0.00183	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.89e-05	0.00183	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	1.88e-05	0.00182	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	1.86e-05	0.00181	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.84e-05	0.00178	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.83e-05	0.00178	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.82e-05	0.00176	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.81e-05	0.00175	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.78e-05	0.00173	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.77e-05	0.00172	CbGpPWpGaD
Trihexyphenidyl—CHRM2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	1.77e-05	0.00172	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.76e-05	0.0017	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.76e-05	0.0017	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.75e-05	0.0017	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.74e-05	0.00168	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.71e-05	0.00166	CbGpPWpGaD
Trihexyphenidyl—CHRM2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	1.71e-05	0.00166	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.69e-05	0.00163	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.64e-05	0.00159	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.61e-05	0.00156	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.61e-05	0.00156	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.61e-05	0.00156	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.54e-05	0.0015	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.54e-05	0.0015	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.54e-05	0.00149	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.53e-05	0.00148	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.47e-05	0.00143	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.47e-05	0.00142	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.43e-05	0.00138	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.42e-05	0.00138	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.41e-05	0.00137	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.41e-05	0.00137	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	1.41e-05	0.00137	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	1.4e-05	0.00136	CbGpPWpGaD
Trihexyphenidyl—CHRM2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	1.38e-05	0.00134	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.35e-05	0.00131	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.34e-05	0.0013	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.34e-05	0.0013	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.33e-05	0.00129	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.28e-05	0.00124	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.27e-05	0.00123	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.27e-05	0.00123	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.26e-05	0.00122	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	1.25e-05	0.00121	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.18e-05	0.00114	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.15e-05	0.00112	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.15e-05	0.00112	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	1.14e-05	0.00111	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.14e-05	0.0011	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.14e-05	0.0011	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.13e-05	0.0011	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.13e-05	0.00109	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.13e-05	0.00109	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.12e-05	0.00109	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—GCLC—chronic obstructive pulmonary disease	1.11e-05	0.00108	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.1e-05	0.00106	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.09e-05	0.00105	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.09e-05	0.00105	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.08e-05	0.00105	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.08e-05	0.00105	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.08e-05	0.00105	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.08e-05	0.00105	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.07e-05	0.00104	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.07e-05	0.00104	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.05e-05	0.00102	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.03e-05	0.001	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.03e-05	0.000997	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.02e-05	0.000987	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—CTGF—chronic obstructive pulmonary disease	1.02e-05	0.000986	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.01e-05	0.00098	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	9.94e-06	0.000963	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	9.91e-06	0.00096	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	9.81e-06	0.000951	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.69e-06	0.000939	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.37e-06	0.000908	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.11e-06	0.000883	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.04e-06	0.000876	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	9.03e-06	0.000875	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	9e-06	0.000872	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	8.91e-06	0.000864	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.72e-06	0.000845	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.66e-06	0.000839	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.27e-06	0.000802	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.22e-06	0.000796	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.95e-06	0.000771	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.92e-06	0.000768	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.92e-06	0.000768	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.91e-06	0.000766	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.87e-06	0.000763	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.85e-06	0.000761	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.82e-06	0.000758	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.71e-06	0.000747	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.57e-06	0.000734	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	7.39e-06	0.000716	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—KL—chronic obstructive pulmonary disease	7.37e-06	0.000714	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.35e-06	0.000713	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—KL—chronic obstructive pulmonary disease	7.3e-06	0.000707	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.18e-06	0.000696	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.04e-06	0.000682	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.82e-06	0.000661	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.81e-06	0.00066	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.8e-06	0.000659	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.73e-06	0.000653	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	6.14e-06	0.000595	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	6.12e-06	0.000593	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.1e-06	0.000591	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.08e-06	0.000589	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	6.06e-06	0.000588	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.04e-06	0.000586	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.02e-06	0.000583	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.79e-06	0.000561	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.77e-06	0.000559	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.58e-06	0.000541	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.56e-06	0.000539	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.54e-06	0.000537	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.52e-06	0.000535	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.52e-06	0.000535	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.51e-06	0.000534	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.5e-06	0.000534	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.47e-06	0.00053	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.33e-06	0.000517	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.32e-06	0.000515	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.27e-06	0.000511	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.26e-06	0.00051	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.96e-06	0.00048	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.94e-06	0.000479	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.89e-06	0.000474	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.89e-06	0.000474	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.68e-06	0.000453	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.65e-06	0.00045	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—ALB—chronic obstructive pulmonary disease	4.63e-06	0.000449	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.45e-06	0.000431	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—NOS3—chronic obstructive pulmonary disease	4.43e-06	0.000429	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.42e-06	0.000428	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.23e-06	0.00041	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.08e-06	0.000395	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.06e-06	0.000394	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.02e-06	0.00039	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.97e-06	0.000385	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.89e-06	0.000377	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.88e-06	0.000376	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.84e-06	0.000372	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.8e-06	0.000368	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.71e-06	0.00036	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.7e-06	0.000359	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.67e-06	0.000355	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.64e-06	0.000353	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.57e-06	0.000346	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.49e-06	0.000338	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.42e-06	0.000331	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.29e-06	0.000319	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.28e-06	0.000318	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.25e-06	0.000315	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.13e-06	0.000304	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.12e-06	0.000303	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.09e-06	0.0003	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3e-06	0.000291	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.98e-06	0.000289	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.97e-06	0.000288	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.94e-06	0.000285	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.87e-06	0.000278	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.74e-06	0.000266	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.68e-06	0.000259	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.67e-06	0.000259	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.64e-06	0.000256	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.63e-06	0.000255	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.46e-06	0.000238	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.45e-06	0.000237	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.42e-06	0.000235	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.41e-06	0.000233	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.4e-06	0.000233	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.38e-06	0.00023	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.02e-06	0.000196	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.02e-06	0.000195	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2e-06	0.000193	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.85e-06	0.000179	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.84e-06	0.000179	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.83e-06	0.000177	CbGpPWpGaD
